ChemPartner PharmaTech Co Ltd
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehe… Read more
ChemPartner PharmaTech Co Ltd - Asset Resilience Ratio
ChemPartner PharmaTech Co Ltd (300149) has an Asset Resilience Ratio of 0.97% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how ChemPartner PharmaTech Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down ChemPartner PharmaTech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥19.20 Million | 0.97% |
| Total Liquid Assets | CN¥19.20 Million | 0.97% |
Asset Resilience Insights
- Limited Liquidity: ChemPartner PharmaTech Co Ltd maintains only 0.97% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ChemPartner PharmaTech Co Ltd Industry Peers by Asset Resilience Ratio
Compare ChemPartner PharmaTech Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for ChemPartner PharmaTech Co Ltd (2014–2024)
The table below shows the annual Asset Resilience Ratio data for ChemPartner PharmaTech Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.05% | CN¥1.05 Million | CN¥2.00 Billion | -0.04pp |
| 2023-12-31 | 0.09% | CN¥2.21 Million | CN¥2.43 Billion | -0.36pp |
| 2021-12-31 | 0.45% | CN¥18.98 Million | CN¥4.22 Billion | -0.04pp |
| 2020-12-31 | 0.49% | CN¥20.08 Million | CN¥4.12 Billion | -1.22pp |
| 2019-12-31 | 1.71% | CN¥64.40 Million | CN¥3.77 Billion | -10.21pp |
| 2017-12-31 | 11.92% | CN¥124.34 Million | CN¥1.04 Billion | -27.54pp |
| 2016-12-31 | 39.46% | CN¥313.00 Million | CN¥793.16 Million | -3.92pp |
| 2015-12-31 | 43.39% | CN¥328.00 Million | CN¥756.00 Million | +38.26pp |
| 2014-12-31 | 5.13% | CN¥38.00 Million | CN¥741.13 Million | -- |